These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32323850)

  • 1. 4,4'‑Bond secalonic acid D targets SP cells and inhibits metastasis in hepatocellular carcinoma.
    Chen L; Cheng MM; Li YP; Lin SF; Zheng QH; Liu QY
    Mol Med Rep; 2020 Jun; 21(6):2624-2632. PubMed ID: 32323850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma.
    Lu P; Sun H; Zhang L; Hou H; Zhang L; Zhao F; Ge C; Yao M; Wang T; Li J
    Mol Med; 2012 Sep; 18(1):1136-46. PubMed ID: 22714713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism.
    Xiong T; Li Z; Huang X; Lu K; Xie W; Zhou Z; Tu J
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G598-G607. PubMed ID: 30817182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of 4,4'-bond secalonic acid D from the marine-derived fungus Penicillium oxalicum with inhibitory property against hepatocellular carcinoma.
    Chen L; Li YP; Li XX; Lu ZH; Zheng QH; Liu QY
    J Antibiot (Tokyo); 2019 Jan; 72(1):34-44. PubMed ID: 30258223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
    Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
    Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
    Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euxanthone exhibits anti-proliferative and anti-invasive activities in hepatocellular carcinoma by inducing pyroptosis: preliminary results.
    Chen YF; Qi HY; Wu FL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8186-8196. PubMed ID: 30556857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
    Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secalonic acid- F inhibited cell growth more effectively than 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
    Gao X; Sun HL; Liu DS; Zhang JR; Zhang J; Yan MM; Pan XH
    Neoplasma; 2017; 64(3):344-350. PubMed ID: 28253713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway.
    Shu G; Mi X; Cai J; Zhang X; Yin W; Yang X; Li Y; Chen L; Deng X
    Toxicol Lett; 2013 Oct; 222(2):91-101. PubMed ID: 23933019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dioscorea nipponica Attenuates Migration and Invasion by Inhibition of Urokinase-Type Plasminogen Activator through Involving PI3K/Akt and Transcriptional Inhibition of NF-[Formula: see text]B and SP-1 in Hepatocellular Carcinoma.
    Hsieh MJ; Yeh CB; Chiou HL; Hsieh MC; Yang SF
    Am J Chin Med; 2016; 44(1):177-95. PubMed ID: 26916922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
    Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC
    Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro.
    Lu WL; Yang T; Song QJ; Fang ZQ; Pan ZQ; Liang C; Jia DW; Peng PK
    J Ethnopharmacol; 2019 Apr; 234():204-215. PubMed ID: 30528882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma.
    Park SY; Han J; Kim JB; Yang MG; Kim YJ; Lim HJ; An SY; Kim JH
    Eur J Cancer; 2014 Jan; 50(2):341-50. PubMed ID: 24161763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma.
    Chen X; Bo L; Zhao X; Chen Q
    Mol Med Rep; 2015 May; 11(5):3900-7. PubMed ID: 25607810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells.
    Lou L; Ye W; Chen Y; Wu S; Jin L; He J; Tao X; Zhu J; Chen X; Deng A; Wang J
    Phytomedicine; 2012 May; 19(7):603-8. PubMed ID: 22349030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo.
    Wei L; Lun Y; Zhou X; He S; Gao L; Liu Y; He Z; Li B; Wang C
    Pharmacol Res; 2019 May; 143():73-85. PubMed ID: 30862605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.